Toxicology Communications Increase your visibility: publish open access

Toxicology Communications

Toxicology Communications is an open access journal that launched in January, 2017. The journal presents a new venue for sharing your clinical observations and investigations. Among the growing numbers of journals that publish case reports, we aim to be the first to focus on toxicology. Toxicology Communications enjoys the support of Taylor & Francis, which publishes impactful journals such as Clinical Toxicology, Critical Reviews in Toxicology, Inhalation Toxicology, and Cutaneous and Ocular Toxicology.

We invite you to share your observations and your experiences. These may include Case Reports presenting one or two patients, or Rapid Communications of preliminary data and case series.

Aims & Scope:

Toxicology Communications publishes case reports and rapid communications in toxicology, of interest to clinical and research toxicologists, pharmacologists and forensic toxicologists. 

Why publish in Toxicology Communications?

  • Increase your visibility
    Articles published open access on our platform are read eight times more than articles published in the traditional subscription model.
  • Lay the foundations for future research
    With your permission, we will deposit your data with Figshare.
  • Promote your ideas freely and openly
    You will retain the copyright of your article, so you could post and share your article to further contribute to new discoveries in the field.

APC Information

There is no charge upon submission. If your paper is accepted, you will be asked to pay the standard article publishing charge (APC) for this journal is £615 / US$800 / €710. Depending on your location these charges may be subject to local taxes. We have agreed a discount on this APC for authors in some institutions. Please click here to learn more about instutional APC discounts.

Instructions for Authors

Please visit the journal's Instructions for Authors page to get more information about the submissions process.

Editorial information

  • Editor-in-Chief: Michael E. Mullins, Washington University School of Medicine St. Louis, Missouri